HOSPITAL UNIVERSITARIO QUIRÓNSALUD MADRID
Departamento
Brigham and Women's Hospital
Boston, Estados UnidosPublicaciones en colaboración con investigadores/as de Brigham and Women's Hospital (6)
2019
-
Comparative efficacy, safety, and cardiovascular outcomes with once-weekly subcutaneous semaglutide in the treatment of type 2 diabetes: Insights from the SUSTAIN 1–7 trials
Diabetes and Metabolism, Vol. 45, Núm. 5, pp. 409-418
-
Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study
The Lancet Diabetes and Endocrinology, Vol. 7, Núm. 12, pp. 899-911
2017
-
Cardiovascular efficacy and safety of bococizumab in high-risk patients
New England Journal of Medicine, Vol. 376, Núm. 16, pp. 1527-1539
2015
-
Effect of sitagliptin on cardiovascular outcomes in type 2 diabetes
New England Journal of Medicine, Vol. 373, Núm. 3, pp. 232-242
2013
-
Edoxaban versus warfarin in patients with atrial fibrillation
New England Journal of Medicine, Vol. 369, Núm. 22, pp. 2093-2104
-
Treatment of idiopathic pulmonary fibrosis with Ambrisentan: A parallel, randomized trial
Annals of Internal Medicine, Vol. 158, Núm. 9, pp. 641-649